David Winchester to Sentinel Lymph Node Biopsy
This is a "connection" page, showing publications David Winchester has written about Sentinel Lymph Node Biopsy.
Connection Strength
1.805
-
Who should have or not have an axillary node dissection with breast cancer? Adv Surg. 2012; 46:1-18.
Score: 0.408
-
Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. J Am Coll Surg. 2011 Jul; 213(1):122-8; discussion 128-9.
Score: 0.389
-
Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009 Jun 20; 27(18):2946-53.
Score: 0.338
-
Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy? Breast J. 2017 Sep; 23(5):554-562.
Score: 0.146
-
Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base. Ann Surg Oncol. 2016 10; 23(10):3337-46.
Score: 0.139
-
Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer. J Am Coll Surg. 2015 Jul; 221(1):71-81.
Score: 0.128
-
The positive sentinel node. J Surg Oncol. 2011 Mar 15; 103(4):326-9.
Score: 0.096
-
Axillary recurrence after sentinel node biopsy. Ann Surg Oncol. 2005 Jan; 12(1):34-40.
Score: 0.063
-
Failure of sentinel lymph node mapping in patients with breast cancer. J Am Coll Surg. 2004 May; 198(5):732-6.
Score: 0.060
-
Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy. Ann Surg Oncol. 2018 Aug; 25(8):2220-2228.
Score: 0.039